GCVIX | RMEBX | GCVIX / RMEBX | |
Total Expense Ratio | 0.56 | 1.07 | 52% |
Annual Report Gross Expense Ratio | 0.66 | 1.07 | 62% |
Fund Existence | 27 years | 11 years | - |
Gain YTD | 3.929 | 9.788 | 40% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 250 | 400,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 527M | 108B | 0% |
Annual Yield % from dividends | 1.21 | 1.11 | 109% |
Returns for 1 year | -2.61 | 9.69 | -27% |
Returns for 3 years | 14.25 | 25.45 | 56% |
Returns for 5 years | 28.13 | 53.83 | 52% |
Returns for 10 years | 58.55 | 77.07 | 76% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
THQ | 15.34 | 0.08 | +0.52% |
abrdn Healthcare Opportunities Fund | |||
KSPY | 27.29 | 0.13 | +0.47% |
KraneShares Hedgeye Hedged Eq Idx ETF | |||
PGHY | 19.99 | 0.01 | +0.05% |
Invesco Glb ex-US High Yld Corp Bd ETF | |||
QULL | 48.32 | N/A | N/A |
ETRACS 2x Lvrgd MSCI US Qlty Fctr TR ETN | |||
EMXC | 64.08 | -0.15 | -0.23% |
iShares MSCI Emerging Mkts ex China ETF |